Clostridium butyricum and Its Derived Extracellular Vesicles Modulate Gut Homeostasis and Ameliorate Acute Experimental Colitis

Preventive and Therapeutic Spermidine Treatment Attenuates Acute Colitis in Mice

(2021) Lingyan Ma et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice

(2021) Umang Jain et al.   SCIENCE

Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age

(2021) Aoyun Li et al.   Microbial Cell Factories

Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis

(2021) Zhenhua Wu et al.   Microbiome

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

(2021) Craig Haifer et al.   Lancet Gastroenterology & Hepatology

Microbiota‐derived extracellular vesicles in interkingdom communication in the gut

(2021) Natalia Díaz‐Garrido et al.   Journal of Extracellular Vesicles

Protective effects of Clostridium butyricum in a murine model of dextran sodium sulfate-induced colitis that involve inhibition of the TLR2 signaling pathway and T helper 17 cells

(2020) Ying Xie et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn’s Disease in Remission

(2020) Zhengxiao Zhang et al.   Journal of Crohns & Colitis

The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome

(2020) Paulina Markowiak-Kopeć et al.   Nutrients

Mucus barrier, mucins and gut microbiota: the expected slimy partners?

(2020) Paola Paone et al.   GUT

Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies

(2020) Jensine A. Grondin et al.   Frontiers in Immunology

Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk

(2019) Ajaz A. Bhat et al.   Frontiers in Physiology

The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans

(2019) Sabina Leanti La Rosa et al.   Nature Communications

Intestinal microbiome as a novel therapeutic target for local and systemic inflammation

(2019) Kazuhiko Uchiyama et al.   PHARMACOLOGY & THERAPEUTICS

Microscopic colitis: pathophysiology and clinical management

(2019) Stephan Miehlke et al.   Lancet Gastroenterology & Hepatology

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

(2019) Israr Khan et al.   Pathogens

Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development

(2019) Laurence Macia et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?

(2018) James A. Tsatsaronis et al.   TRENDS IN MICROBIOLOGY

Immunomodulatory Effects of Pneumococcal Extracellular Vesicles on Cellular and Humoral Host Defenses

(2018) Mario Codemo et al.   mBio

Comparative biogeography of the gut microbiome between Jinhua and Landrace pigs

(2018) Yingping Xiao et al.   Scientific Reports

Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells

(2018) Claudia Burrello et al.   Nature Communications

Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

(2017) Stephan J. Ott et al.   GASTROENTEROLOGY

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

The outer membrane vesicles: Secretion system type zero

(2017) Andrea Guerrero-Mandujano et al.   TRAFFIC

Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice

(2017) María-José Fábrega et al.   Frontiers in Microbiology

Mechanisms of inflammation-driven bacterial dysbiosis in the gut

(2016) M Y Zeng et al.   Mucosal Immunology

Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium

(2016) Qianpeng Zhang et al.   Scientific Reports

Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3T, a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing

(2014) Marjan Steppe et al.   FOOD AND CHEMICAL TOXICOLOGY

Intestinal barrier in inflammatory bowel disease

(2014) Lena Antoni   WORLD JOURNAL OF GASTROENTEROLOGY

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

(2013) Morgan G I Langille et al.   NATURE BIOTECHNOLOGY

Mucins in inflammatory bowel diseases and colorectal cancer

(2011) Yong H Sheng et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria

(2010) Chin Wen Png et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Importance of disrupted intestinal barrier in inflammatory bowel diseases

(2010) Saʼad Y. Salim et al.   INFLAMMATORY BOWEL DISEASES

Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine

(2009) Petra Louis et al.   FEMS MICROBIOLOGY LETTERS

Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn’s disease

(2008) V. Strugala et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE